1. Home
  2. Analysis
  3. Viagra
  4. Xeljanz-xr

Viagra and Xeljanz xr drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viagra (sildenafil citrate) and Xeljanz xr (tofacitinib citrate). Common drug interactions include pneumonia among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Viagra and Xeljanz xr. It is created by eHealthMe based on reports of 8 people who take the same drugs from the FDA, and is updated regularly.

What is Viagra?

Viagra has active ingredients of sildenafil citrate. It is often used in erection problems. eHealthMe is studying from 63,865 Viagra users. Check the latest studies of Viagra.

What is Xeljanz xr?

Xeljanz xr has active ingredients of tofacitinib citrate. eHealthMe is studying from 106,446 Xeljanz xr users. Check the latest studies of Xeljanz xr.

On Jul, 06, 2026

8 people who take Viagra and Xeljanz xr together, and have interactions are studied.

Viagra and Xeljanz xr drug interactions.

What are the common drug interactions of Viagra and Xeljanz Xr, by gender? *:

female:

  1. Pneumonia

male:

  1. Arthralgia (joint pain)
  2. Cataract (clouding of the lens inside the eye)
  3. Nodule (a growth of abnormal tissue)
  4. Overweight
  5. Pain in extremity
  6. Pancreatitis (inflammation of pancreas)
  7. Pneumonia
  8. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  9. Viral upper respiratory tract infection
  10. Chills (felling of cold)

What are the common drug interactions of Viagra and Xeljanz Xr, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chills (felling of cold)

50-59:

  1. Cataract (clouding of the lens inside the eye)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Drug ineffective
  4. Overweight
  5. Pancreatitis (inflammation of pancreas)
  6. Pneumonia
  7. Viral upper respiratory tract infection

60+:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Foreign body in eye (foreign particle in eye)
  3. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

* Approximation only. Some reports may have incomplete information.

Do you take Viagra and Xeljanz xr?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viagra and Xeljanz xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viagra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xeljanz xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viagra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xeljanz xr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on sildenafil citrate and tofacitinib citrate (the active ingredients of Viagra and Xeljanz xr, respectively), and Viagra and Xeljanz xr (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.